Provided by Tiger Fintech (Singapore) Pte. Ltd.

iHuman

2.08
-0.0600-2.80%
Volume:336.36K
Turnover:768.25K
Market Cap:108.62M
PE:7.48
High:2.40
Open:2.18
Low:2.08
Close:2.14
Loading ...

Press Release: Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer

Dow Jones
·
08 Jan

iHuman Inc. Reports Q3 2024 Financial Results and Strategic Expansions

TIPRANKS
·
26 Dec 2024

iHuman's Q3 MAUs Rose 14.8% YoY To 29.12M

Benzinga
·
26 Dec 2024

iHuman Q3 Adj EPADS $0.07 Down From $0.14 YoY, Sales $34.12M Down From $35.84M YoY

Benzinga
·
26 Dec 2024

BRIEF-Ihuman Q3 Diluted Net Income Per ADS US$0.07

Reuters
·
26 Dec 2024

Ihuman Q3 Gross Margin 68.4%

THOMSON REUTERS
·
26 Dec 2024

Ihuman Q3 Operating Expenses RMB 143.2 Million

THOMSON REUTERS
·
26 Dec 2024

Ihuman Inc: Qtrly Basic and Diluted Net Income per Ads Were RMB0.48 (US$0.07) and RMB0.47 (US$0.07)

THOMSON REUTERS
·
26 Dec 2024

Ihuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

THOMSON REUTERS
·
26 Dec 2024

Press Release: iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

Dow Jones
·
26 Dec 2024

ZCCM-IH Invests $10M in CEC-R Green Bond for Solar Project Expansion

TIPRANKS
·
18 Dec 2024

Returns At iHuman (NYSE:IH) Are On The Way Up

Simply Wall St.
·
18 Dec 2024

Closing Bell: Another gloomy day for tech stocks as traders await US CPI data

Stockheads
·
11 Dec 2024

ASX Lunch Wrap: S32 tumbles amid Mozambique unrest; Chemist Warehouse could be listed by February

Stockheads
·
11 Dec 2024

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

GlobeNewswire
·
15 Nov 2024

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire
·
12 Nov 2024